The U. S. Supreme Court established limitations on personal jurisdiction over non-resident corporate defendants in state court “mass” actions in Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco Cty., 137 S. Ct 1773 (June 17, 2017) (hereafter “BMS”). BMS’s key holding was that the necessary nexus between an appropriate court for a mass action and a corporate defendant required more than just the company’s connections in the state and the alleged similarity of claims by resident plaintiffs and non-resident plaintiffs. The practical effect is ...
Recent Updates
- When the AI Agent Goes Off-Script: The First Incident Playbook for Frontier AI
- Revised New York City Fair Chance Rules Take Effect October 30
- Executive Order 14398 Survives Preliminary Challenge: What Contractors and Subcontractors Should Know with Respect to DEI
- How Employers Can Manage Shorter EEOC Charge Response Deadlines
- Menopause as a Protected Class: Growing Trend or a Hot Flash?